Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value: $2.897B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | 11,584,280 | $315M | 10.9% | $11.63 | +151.5% | SHS | G72800108 |
| APLS | APELLIS PHARMACEUTICALS INC | 5,183,431 | $234M | 8.1% | $40.43 | +12.8% | COM | 03753U106 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,868,145 | $215M | 7.4% | $75.74 | -2.9% | COM | 803607100 |
| — | SEAGEN INC | 1,008,628 | $178M | 6.2% | $176.94 | — | COM | 81181C104 |
| GLPG | GALAPAGOS NV | 3,197,500 | $178M | 6.2% | $55.99 | — | SPON ADR | 36315X101 |
| ANAB | ANAPTYSBIO INC | 7,521,024 | $153M | 5.3% | $23.15 | -4.3% | COM | 032724106 |
| XNCR | XENCOR INC | 5,282,416 | $145M | 5.0% | $33.50 | -26.4% | COM | 98401F105 |
| ARVN | ARVINAS INC | 3,123,300 | $131M | 4.5% | $59.39 | -15.5% | COM | 04335A105 |
| KURA | KURA ONCOLOGY INC | 6,638,371 | $122M | 4.2% | $18.76 | -23.3% | COM | 50127T109 |
| — | MORPHIC HLDG INC | 3,951,566 | $85.75M | 3.0% | $29.75 | — | COM | 61775R105 |
| ACAD | ACADIA PHARMACEUTICALS INC | 5,991,479 | $84.42M | 2.9% | $22.11 | -15.5% | COM | 004225108 |
| ZLAB | ZAI LAB LT | 2,431,885 | $84.34M | 2.9% | $43.18 | — | ADR | 98887Q104 |
| RVMD | REVOLUTION MEDICINES INC | 4,278,069 | $83.38M | 2.9% | $20.15 | -3.4% | COM | 76155X100 |
| RLAY | RELAY THERAPEUTICS INC | 3,723,541 | $62.37M | 2.2% | $28.76 | -25.5% | COM | 75943R102 |
| — | REATA PHARMACEUTICALS INC | 1,975,611 | $60.04M | 2.1% | $32.76 | — | CL A | 75615P103 |
| ALLO | ALLOGENE THERAPEUTICS INC | 4,488,200 | $51.16M | 1.8% | $8.88 | 0.0% | COM | 019770106 |
| ARGX | ARGENX SE | 125,000 | $47.36M | 1.6% | $315.31 | — | SPONSORED ADR | 04016X101 |
| — | 2SEVENTY BIO INC | 3,495,943 | $46.15M | 1.6% | $21.76 | — | COMMON STOCK | 901384107 |
| NUVB | NUVATION BIO INC | 13,896,543 | $45.02M | 1.6% | $11.16 | -60.9% | COM CL A | 67080N101 |
| AVIR | ATEA PHARMACEUTICALS INC | 6,340,639 | $45.02M | 1.6% | $14.25 | -52.1% | COM | 04683R106 |
| — | CEREVEL THERAPEUTICS HLDNG I | 1,646,260 | $43.53M | 1.5% | $35.01 | — | COM | 15678U128 |
| ALEC | ALECTOR INC | 4,056,548 | $41.22M | 1.4% | $19.56 | -49.0% | COM | 014442107 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,759,505 | $40.1M | 1.4% | $27.15 | -45.2% | COM | 05370A108 |
| DSGN | DESIGN THERAPEUTICS INC | 2,634,178 | $36.88M | 1.3% | $22.94 | -41.1% | COM | 25056L103 |
| VYGR | VOYAGER THERAPEUTICS INC | 4,753,907 | $28.1M | 1.0% | $3.51 | — | COM | 92915B106 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,330,263 | $24.81M | 0.9% | $22.08 | -9.6% | COM | 22663K107 |
| GERN | GERON CORP | 14,168,988 | $21.96M | 0.8% | $1.11 | +26.7% | COM | 374163103 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 895,503 | $19.08M | 0.7% | $16.92 | +21.3% | COM | 03969K108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,359,808 | $18.78M | 0.6% | $23.14 | -67.3% | COM | 28036F105 |
| JANX | JANUX THERAPEUTICS INC | 1,421,319 | $17.35M | 0.6% | $22.27 | -46.8% | COM | 47103J105 |
| VTYX | VENTYX BIOSCIENCES INC | 1,300,000 | $15.9M | 0.5% | $18.95 | -21.1% | COM | 92332V107 |
| EXEL | EXELIXIS INC | 760,000 | $15.82M | 0.5% | $19.53 | +5.5% | Call | 30161Q104 |
| ORIC | ORIC PHARMACEUTICALS INC | 3,418,068 | $15.31M | 0.5% | $30.24 | -86.8% | COM | 68622P109 |
| CGEM | CULLINAN ONCOLOGY INC | 1,169,889 | $15M | 0.5% | $11.34 | 0.0% | COM | 230031106 |
| INCY | INCYTE CORP | 182,783 | $13.89M | 0.5% | $75.93 | 0.0% | COM | 45337C102 |
| OVID | OVID THERAPEUTICS INC | 6,117,400 | $13.15M | 0.5% | $3.32 | -27.2% | COM | 690469101 |
| — | CHINOOK THERAPEUTICS INC | 690,000 | $12.07M | 0.4% | $16.36 | — | COM | 16961L106 |
| — | GRACELL BIOTECHNOLOGIES INC | 1,921,310 | $10.57M | 0.4% | $2.93 | — | SPONSORED ADS | 38406L103 |
| TNGX | TANGO THERAPEUTICS INC | 2,302,065 | $10.43M | 0.4% | $8.02 | -24.5% | COM | 87583X109 |
| — | AKOUOS INC | 1,975,984 | $9.267M | 0.3% | $22.50 | — | COM | 00973J101 |
| — | HOOKIPA PHARMA INC | 5,000,000 | $8.15M | 0.3% | $2.28 | — | COM | 43906K100 |
| — | PRECISION BIOSCIENCES INC | 5,035,971 | $8.058M | 0.3% | $1.60 | — | COM | 74019P108 |
| — | SURFACE ONCOLOGY INC | 4,653,000 | $7.631M | 0.3% | $2.94 | — | COM | 86877M209 |
| — | NGM BIOPHARMACEUTICALS INC | 541,108 | $6.937M | 0.2% | $15.25 | — | COM | 62921N105 |
| — | FRAZIER LIFESCIENCES ACQU CO | 587,615 | $5.8M | 0.2% | $9.80 | — | CL A SHS | G3710A105 |
| — | ITEOS THERAPEUTICS INC | 279,999 | $5.768M | 0.2% | $21.93 | — | COM | 46565G104 |
| — | JIYA ACQUISITION CORP | 500,000 | $4.94M | 0.2% | $10.30 | — | COM CL A | 47760M102 |
| — | ALIGOS THERAPEUTICS INC | 3,948,360 | $4.778M | 0.2% | $2.37 | — | COM | 01626L105 |
| — | SELECTA BIOSCIENCES INC | 3,500,000 | $4.585M | 0.2% | $1.31 | — | COM | 816212104 |
| — | AVEO PHARMACEUTICALS INC | 647,489 | $4.248M | 0.1% | $6.56 | — | COM NEW | 053588307 |
| — | HEALTH SCIENCES ACQ CORP 2 | 400,000 | $3.984M | 0.1% | $11.00 | — | ORD SHS | G4411D109 |
| ERAS | ERASCA INC | 678,441 | $3.779M | 0.1% | $20.63 | -68.3% | COM | 29479A108 |
| — | GRAPHITE BIO INC | 1,162,179 | $3.196M | 0.1% | $9.17 | — | COM | 38870X104 |
| — | NUVATION BIO INC | 963,333 | $3.121M | 0.1% | $10.45 | — | *W EXP 07/07/202 | 67080N119 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 115,200 | $3.106M | 0.1% | — | — | Put | 15117B202 |
| SPRY | SILVERBACK THERAPEUTICS INC | 575,359 | $2.44M | 0.1% | $20.59 | -83.1% | COM | 82835W108 |
| — | TEMPEST THERAPEUTICS INC | 1,031,268 | $2.217M | 0.1% | $2.15 | — | COM | 87978U108 |
| — | KINNATE BIOPHARMA INC | 175,000 | $2.207M | 0.1% | $25.42 | — | COM | 49705R105 |
| — | EUCRATES BIOMEDICAL ACQU COR | 200,000 | $1.98M | 0.1% | $9.98 | — | SHS | G3141W106 |
| — | BCLS ACQUISITION CORP | 200,000 | $1.98M | 0.1% | $11.14 | — | COM CL A | G0904B105 |
| — | 5 01 ACQUISITION CORP | 200,000 | $1.98M | 0.1% | $10.17 | — | COM CL A | 33836P105 |
| — | VERVE THERAPEUTICS INC | 98,593 | $1.507M | 0.1% | $60.25 | — | COM | 92539P101 |
| DYN | DYNE THERAPEUTICS INC | 215,000 | $1.477M | 0.1% | $21.96 | -68.6% | COM | 26818M108 |
| — | ARYA SCIENCES ACQU CORP IV | 150,000 | $1.472M | 0.1% | $10.47 | — | CL A | G31659108 |
| OLMA | OLEMA PHARMACEUTICALS INC | 353,701 | $1.44M | 0.0% | $3.17 | 0.0% | COM | 68062P106 |
| — | MERSANA THERAPEUTICS INC | 310,960 | $1.437M | 0.0% | $3.99 | — | COM | 59045L106 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 292,320 | $1.424M | 0.0% | $20.63 | — | SPONSORED ADS | 152309100 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,046,700 | $1.256M | 0.0% | $1.76 | — | COM | 00773U108 |
| — | KRONOS BIO INC | 326,780 | $1.189M | 0.0% | $29.87 | — | COM | 50107A104 |
| — | TURMERIC ACQUISITION CORP | 100,000 | $993K | 0.0% | $9.77 | — | CL A | G9127T108 |
| — | EUCRATES BIOMEDICAL ACQU COR | 66,666 | $660K | 0.0% | $9.90 | — | *W EXP 10/23/202 | G3141W122 |
| — | FRAZIER LIFESCIENCES ACQU CO | 66,665 | $658K | 0.0% | $9.77 | — | *W EXP 11/30/202 | G3710A113 |
| — | PARDES BIOSCIENCES INC | 200,000 | $614K | 0.0% | $16.37 | — | COM | 69945Q105 |
| — | PRAXIS PRECISION MEDICINES I | 210,100 | $515K | 0.0% | $2.45 | — | COM | 74006W108 |
| — | OMEGA ALPHA SPAC | 50,000 | $493K | 0.0% | $9.90 | — | CL A | G6749V107 |
| — | EVELO BIOSCIENCES INC | 200,417 | $423K | 0.0% | $2.11 | — | COM | 299734103 |
| — | CAREMAX INC | 100,000 | $363K | 0.0% | $12.90 | — | *W EXP 06/08/202 | 14171W111 |
| — | TURMERIC ACQUISITION CORP | 33,333 | $331K | 0.0% | $9.78 | — | *W EXP 10/08/202 | G9127T124 |
| — | BOLT BIOTHERAPEUTICS INC | 150,000 | $306K | 0.0% | $32.91 | — | COM | 097702104 |
| SRZNW | SURROZEN INC | 66,665 | $200K | 0.0% | $7.07 | — | *W EXP 08/01/203 | 86889P117 |